National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

This is VAERS ID 1232476

Case Details

VAERS ID: 1232476 (history)  
Form: Version 2.0  
Age: 53.0  
Sex: Female  
Location: Florida  
   Days after vaccination:18
Submitted: 0000-00-00
Entered: 2021-04-20
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Private       Purchased by: ?
Symptoms: Anticoagulant therapy, Cerebral venous sinus thrombosis, Full blood count normal, Headache, Magnetic resonance imaging head normal, Metabolic function test normal, Platelet count normal, Venogram abnormal
SMQs:, Embolic and thrombotic events, venous (narrow), Central nervous system vascular disorders, not specified as haemorrhagic or ischaemic (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Baby Aspirin, Lorazepam, Pepcid, Protonix
Current Illness:
Preexisting Conditions: Myocardial infarction (x4), colorectal cancer treated in 2005, tobacco use (1/2 ppd), gastritis, migraine; back pain, herniated disc, lumbar canal stenosis, hysterectomy, obesity, anxiety
Allergies: Augmentin, Ampicillin, Erythromycin, Percocet
Diagnostic Lab Data: CT Head Venogram 4/17/21, MRI Brain 4/18/21
CDC Split Type:

Write-up: Patient presented to Emergency Department on 4/17/21 with a severe headache that started 5-7 days prior. CBC and Chem-8 were normal with platelets of 314. Findings from CT head venogram showed irregularities of the left transverse sinus with possible sinus thrombosis. Patient was admitted for further work-up and treatment. Patient was followed by Neurology. On 4/18 MRI revealed no cavernoma seen and no stroke or hemorrhage. Per Neurology, the areas of filling defects seen on CTV are still present which could be nonocclusive thrombus vs stenosis with prominent arachnoid granulations, but given history and risk factors, would treat as cerebral sinus venous thrombosis. Patient was treated with heparin then transitioned to apixaban, which she was discharged on. Patient was instructed to follow up with neurology in 3 months for a repeat CTV. Patient was discharged 4/19/21.

New Search

Link To This Search Result:

Government Disclaimer on use of this data

Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166